Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × Heart Failure × Clear all

Phase

Phase NA 10 Phase 3 2 Phase 2 2 Phase 4 1 Phase 1/2 1

Status

Recruiting 4 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 45 Neoplasms 34 Carcinoma, Hepatocellular 34 Colorectal Neoplasms 23 Polycystic Ovary Syndrome 19 Stomach Neoplasms 17 Carcinoma, Non-Small-Cell Lung 15 Prostatic Neoplasms 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Pancreatic Neoplasms 12 Recurrence 11 Lymphoma 11 Liver Neoplasms 10 Leukemia, Myeloid, Acute 9 Esophageal Neoplasms 9 Colonic Neoplasms 9 Pain 8 Lung Neoplasms 8 Leiomyoma 8 Urinary Bladder Neoplasms 7 Uterine Cervical Neoplasms 6 Pain, Postoperative 6 Neoplasm Metastasis 6 Lymphoma, Follicular 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Keratosis, Actinic 6 Infertility 6 NSCLC 5 Multiple Myeloma 5 Head and Neck Neoplasms 5

Interventions

Spironolactone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06005259 2023-08-22

SPIROTOX

University of Sao Paulo

Phase 4 Unknown

Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡